Defining response to anti-VEGF therapies in neovascular AMD

The introduction of anti-vascular endothelial growth factor (anti-VEGF) has made significant impact on the reduction of the visual loss due to neovascular age-related macular degeneration (n-AMD). There are significant inter-individual differences in response to an anti-VEGF agent, made more complex...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eye (Lond)
Hlavní autoři: Amoaku, W M, Chakravarthy, U, Gale, R, Gavin, M, Ghanchi, F, Gibson, J, Harding, S, Johnston, R L, Kelly, S, Lotery, A, Mahmood, S, Menon, G, Sivaprasad, S, Talks, J, Tufail, A, Yang, Y
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469673/
https://ncbi.nlm.nih.gov/pubmed/25882328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.48
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky